Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma
Abstract The incidence and mortality rates of intrahepatic cholangiocarcinoma have been rising worldwide. Few patients present an early-stage disease that is amenable to curative surgery and after resection, high recurrence rates persist. To identify new independent marker related to aggressive beha...
Guardado en:
Autores principales: | Michele Simbolo, Caterina Vicentini, Andrea Ruzzenente, Matteo Brunelli, Simone Conci, Matteo Fassan, Andrea Mafficini, Borislav Rusev, Vincenzo Corbo, Paola Capelli, Emilio Bria, Serena Pedron, Giona Turri, Rita T. Lawlor, Giampaolo Tortora, Claudio Bassi, Alfredo Guglielmi, Aldo Scarpa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/43514a3462ab48c3877101c0b0918453 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA qualification workflow for next generation sequencing of histopathological samples.
por: Michele Simbolo, et al.
Publicado: (2013) -
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
por: Serifis N, et al.
Publicado: (2021) -
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma
por: Chen,Yijie, et al.
Publicado: (2015) -
Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study
por: Tian-hua Yu, et al.
Publicado: (2021) -
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
por: Sabina Di Matteo, et al.
Publicado: (2021)